Advertisement
Screener

CAMP4 Therapeutics Corporation (CAMP) P/E Ratio

2.8 / 5 stars · 68/120 Roast Me

Camp4 Therapeutics Corp PE Ratio

The price-to-earnings (P/E) ratio tells you how many dollars investors pay for each dollar of a company's annual profit. It is market capitalization divided by net income over the trailing four quarters, meaning the four most recent filed quarters added together, and the table shows both amounts. A higher P/E means investors are paying more for each dollar of current earnings, often because they expect profits to grow; a negative P/E means the company lost money over those four quarters. Each point uses the filed share count and the last closing price on or before that quarter-end date, never today's price.

  • Camp4 Therapeutics Corp pe ratio for the quarter ending 2026-06-30 was -2.12, a change of -1.55 year-over-year.
  • Camp4 Therapeutics Corp pe ratio for the quarter ending 2026-03-31 was -2.68, a change of -1.12 year-over-year.
  • Camp4 Therapeutics Corp pe ratio for the quarter ending 2025-12-31 was -3.95, a change of -1.92 year-over-year.
  • Camp4 Therapeutics Corp pe ratio for the quarter ending 2025-09-30 was -2.65.
  • Camp4 Therapeutics Corp pe ratio for fiscal 2026 was -2.12.
  • Camp4 Therapeutics Corp pe ratio for fiscal 2025 was -3.95, a change of -1.92 from fiscal 2024.
  • Camp4 Therapeutics Corp pe ratio for fiscal 2024 was -2.03.
Available history
2024-12-31 to 2026-06-30
Data captured

Historical PE Ratio

DatePE RatioMarket capitalizationNet income 12 month
2026-06-30-2.12$227.7M-$107.24M
2026-03-31-2.68$231.07M-$86.3M
2025-12-31-3.95$317.38M-$80.4M
2025-09-30-2.65$141.58M-$53.4M
2025-06-30-0.57$29.74M-$51.78M
2025-03-31-1.56$80.63M-$51.77M
2024-12-31-2.03$105.16M-$51.79M

Annual PE Ratio

DatePE RatioMarket capitalizationNet income 12 month
2026-06-30-2.12$227.7M-$107.24M
2025-12-31-3.95$317.38M-$80.4M
2024-12-31-2.03$105.16M-$51.79M

Similar stocks

Stock NameCountryMarket CapPE Ratio
MACROGENICS INC (MGNX)United States$0.242B-20.11
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51